MilliporeSigma Brochures

  1. Understand Your Stability Programs 8/14/2025

    A stability program evaluates how pharmaceutical and biologic products maintain potency, purity, and quality over time, which ensures safety, effectiveness, and regulatory compliance.

  2. AAV Gene Therapy: Charting The Course Through Clinical Challenges 8/11/2025

    Clinical holds in AAV gene therapy often stem from CMC and quality issues. Learn about testing services that help developers navigate regulatory hurdles and accelerate therapeutic progress.

  3. A High-Purity Excipient Suitable For High-Risk Vaccine Applications 7/21/2025

    Discover an ultra-pure, sustainable alternative to shark-derived squalene. With ≥99% purity and Ph. Eur. compliance, it ensures safety, consistency, and ethical sourcing for innovation.

  4. An Alternative Suitable For High-Risk Applications 7/21/2025

    Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Explore more about its vital role in modern immunology innovation.

  5. Viral Clearance Services 6/27/2025

    Ensure safety with expert-led viral clearance studies. Our global team delivers regulatory-compliant, scientifically robust solutions to eliminate viral risks and support your product’s success.

  6. AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone 6/17/2025

    Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.

  7. Conical Tube Sampling Unit 6/16/2025

    Enhance your biopharmaceutical sampling process with compact, centrifuge-ready containers that are designed for flexibility, aseptic transfer, and contamination control at any production stage.

  8. Ensuring Success With Manufacturing Risk Assessment 4/17/2025

    Discover how early manufacturing risk assessments lay the foundation for technology transfer strategies to ensure smooth transitions, mitigate risks, and enhance efficiency with proactive gap analysis by CMC experts.

  9. API Stability Combined With Rapid Disintegration 4/2/2025

    Enhance tablet effectiveness across various dosages with an excipient that offers excellent compressibility and stability for APIs, which eliminates the need for intense processing and provides rapid disintegration.

  10. Chemically Defined Cell Culture Feed 3/27/2025

    Discover a highly concentrated, pH-neutral, non-animal-origin feed for CHO cell-based systems to enhance monoclonal antibody production with consistent, simplified, and flexible biomanufacturing processes.